Futura Medical plc (FUM.L)
LSE · GBp · Healthcare · Biotechnology
£0.17 (-9.09%) as of
Key statistics
- Market cap
- 2.52M
- Forward P/E
- -0.23
- EPS (TTM)
- -0.0100
- Dividend yield
- 0.00%
- 52-week range
- 0.1600 – 3.0900
- Beta
- 0.14
- Revenue (TTM)
- 2.32M
- Profit margin
- -158.21%
- Volume
- 4.79M
About Futura Medical plc
Futura Medical plc research, develops, and commercializes pharmaceutical and healthcare products for sexual health. The company's lead product includes Eroxon, a topical treatment for erectile dysfunction. It also develops WSD4000 for the treatment of sexual dysfunction in women. The company operates in the United Kingdom, the European Union, the United States, and internationally. Futura Medical plc was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
- Sector
- Healthcare
- Industry
- Biotechnology
- Headquarters
- Guildford, United Kingdom
- Employees
- 13
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.